What is a stock summary page? Click here for an overview.
Business Description
Merit Medical Systems Inc
NAICS : 339112
SIC : 3841
ISIN : US5898891040
Share Class Description:
FRA:MM3: Ordinary SharesDescription
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.47 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.58 | |||||
| Debt-to-EBITDA | 2.69 | |||||
| Interest Coverage | 5 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.72 | |||||
| Beneish M-Score | -2.44 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.8 | |||||
| 3-Year EBITDA Growth Rate | 22.6 | |||||
| 3-Year EPS without NRI Growth Rate | 45.9 | |||||
| 3-Year FCF Growth Rate | 14.9 | |||||
| 3-Year Book Growth Rate | 8.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 8.3 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 6.97 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.82 | |||||
| 9-Day RSI | 28.1 | |||||
| 14-Day RSI | 32.74 | |||||
| 3-1 Month Momentum % | 4.35 | |||||
| 6-1 Month Momentum % | 12.28 | |||||
| 12-1 Month Momentum % | 44.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.27 | |||||
| Quick Ratio | 2.85 | |||||
| Cash Ratio | 1.74 | |||||
| Days Inventory | 155.73 | |||||
| Days Sales Outstanding | 49.57 | |||||
| Days Payable | 30.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.3 | |||||
| Shareholder Yield % | -7.33 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.43 | |||||
| Operating Margin % | 11.51 | |||||
| Net Margin % | 8.87 | |||||
| FCF Margin % | 13.54 | |||||
| ROE % | 9.36 | |||||
| ROA % | 5.09 | |||||
| ROIC % | 7.66 | |||||
| 3-Year ROIIC % | 11.61 | |||||
| ROC (Joel Greenblatt) % | 23.06 | |||||
| ROCE % | 8.37 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 45.56 | |||||
| Forward PE Ratio | 24.13 | |||||
| PE Ratio without NRI | 32.09 | |||||
| Shiller PE Ratio | 102.88 | |||||
| Price-to-Owner-Earnings | 34.19 | |||||
| PEG Ratio | 1.54 | |||||
| PS Ratio | 4.05 | |||||
| PB Ratio | 3.94 | |||||
| Price-to-Tangible-Book | 13 | |||||
| Price-to-Free-Cash-Flow | 30.14 | |||||
| Price-to-Operating-Cash-Flow | 24.91 | |||||
| EV-to-EBIT | 32.45 | |||||
| EV-to-EBITDA | 19.87 | |||||
| EV-to-Forward-EBITDA | 16.52 | |||||
| EV-to-Revenue | 4.34 | |||||
| EV-to-Forward-Revenue | 3.99 | |||||
| EV-to-FCF | 32.18 | |||||
| Price-to-GF-Value | 1.05 | |||||
| Price-to-Projected-FCF | 2.31 | |||||
| Price-to-DCF (Earnings Based) | 1.36 | |||||
| Price-to-DCF (FCF Based) | 1.22 | |||||
| Price-to-Median-PS-Value | 1.29 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.28 | |||||
| Price-to-Graham-Number | 4.31 | |||||
| Earnings Yield (Greenblatt) % | 3.08 | |||||
| FCF Yield % | 3.35 | |||||
| Forward Rate of Return (Yacktman) % | 22.12 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Merit Medical Systems Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1,257.008 | ||
| EPS (TTM) (€) | 1.88 | ||
| Beta | 0.2 | ||
| 3-Year Sharpe Ratio | 0.74 | ||
| 3-Year Sortino Ratio | 1.27 | ||
| Volatility % | 22.03 | ||
| 14-Day RSI | 32.74 | ||
| 14-Day ATR (€) | 2.778897 | ||
| 20-Day SMA (€) | 92.825 | ||
| 12-1 Month Momentum % | 44.36 | ||
| 52-Week Range (€) | 65.5 - 105 | ||
| Shares Outstanding (Mil) | 59.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Merit Medical Systems Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Merit Medical Systems Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Merit Medical Systems Inc Frequently Asked Questions
What is Merit Medical Systems Inc(FRA:MM3)'s stock price today?
The current price of FRA:MM3 is €84.50. The 52 week high of FRA:MM3 is €105.00 and 52 week low is €65.50.
When is next earnings date of Merit Medical Systems Inc(FRA:MM3)?
The next earnings date of Merit Medical Systems Inc(FRA:MM3) is 2025-04-30 Est..
Does Merit Medical Systems Inc(FRA:MM3) pay dividends? If so, how much?
Merit Medical Systems Inc(FRA:MM3) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers